Blood—Brain Barrier 2001
DOI: 10.1007/978-1-4615-0579-2_27
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of Poly (Carboxyphenoxypropane-Sebacic Anhydride) for the Delivery of Drugs to the Brain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2009
2009
2009
2009

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 12 publications
0
3
0
Order By: Relevance
“…Methods developed to deliver neuropeptides via liposomes and capsular carriers have not been effective. 16,32,[58][59][60] Early sustained-release formulations of TRH-containing Copoly((ϩ)-lactic/glycolic acid) (PLGA) microspheres injected subcutaneously caused a dose-dependent shortening of pentobarbitone-induced sleeping time 61 and improved experimentally induced parkinsonism 62 in rats, but at levels known to stimulate an unwanted endocrine response. Therefore, sustained-release preparations loaded with neuropeptides in combination with the advantages obtained from intranasal delivery may provide the key elements for attaining more prolonged, site-specific effects while reducing unwanted side effects.…”
Section: Effect Of Intranasal Delivery Of Trh Nanoparticles On Kindlimentioning
confidence: 99%
See 2 more Smart Citations
“…Methods developed to deliver neuropeptides via liposomes and capsular carriers have not been effective. 16,32,[58][59][60] Early sustained-release formulations of TRH-containing Copoly((ϩ)-lactic/glycolic acid) (PLGA) microspheres injected subcutaneously caused a dose-dependent shortening of pentobarbitone-induced sleeping time 61 and improved experimentally induced parkinsonism 62 in rats, but at levels known to stimulate an unwanted endocrine response. Therefore, sustained-release preparations loaded with neuropeptides in combination with the advantages obtained from intranasal delivery may provide the key elements for attaining more prolonged, site-specific effects while reducing unwanted side effects.…”
Section: Effect Of Intranasal Delivery Of Trh Nanoparticles On Kindlimentioning
confidence: 99%
“…64 Our D,L-polylactide nanoparticles are submicronsized (ϳ100 nm) polymeric colloidal particles, with a therapeutic agent of interest (i.e., TRH) entrapped within their polymeric matrix. [58][59][60] The use of TRH-NPs is hypothesized to increase target tissue bioavailability after intranasal delivery.…”
Section: Effect Of Intranasal Delivery Of Trh Nanoparticles On Kindlimentioning
confidence: 99%
See 1 more Smart Citation